The Georgia Institute of Technology in Atlanta, USA, has announced successful tests to determine whether batches of Roche's antiviral Tamiflu (oseltamivir) are genuine, according to a report by Yahoo! News. Instead of taking up to an hour, which is the time required for the high-performance liquid chromatography test, the desorption electrospray ionization mass spectrometry (DESI-MS) technique developed at the Georgia center can analyze a drug sample in less than a minute, according to Facundo Fernandez. The process is an improvement on previous mass spectrometry methods devised by Prof Fernandez and colleagues at the GIT (Marketletter June 26, 2006).
Prof Fernandez explained that, in order to test the accuracy of the DESI-MS process, he obtained samples of Tamiflu from on-line pharmacies, a notorious source of counterfeit or substandard products (Marketletters passim). Due to the drug's cost, about $6.50 per tablet, and its use as a prophylatic and treatment for avian influenza, he explained, Tamiflu is a target for fake drug manufacturers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze